Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Graphic Packaging Holding Company (GPK) Shareholders To Inquire About Securities Fraud Class Action

businesswire.com
GPK

Deluxe to Power Payment Solutions for Dollar Bank's Business Customers

businesswire.com
DLX

CME Group Inc. Announces Preliminary Results of 2026 Annual Meeting

prnewswire.com
CME

Harris Teeter Offers VIC Card Members Daily Deals, 4x Fuel Points During Week-Long Customer Appreciation Sale May 13-19

prnewswire.com
KR

A2Z Cust2Mate Secures Approval for $30 Million Non-Dilutive Financing to Scale Smart Cart Manufacturing & Deployment

prnewswire.com
AZ

DEADLINE ALERT for ATRA, COTY, SMCI, IBRX: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

globenewswire.com
ATRA COTY SMCI IBRX

BeOne Medicines旗下BEQALZI ™ (sonrotoclax)獲美國FDA核准,成首款及唯一用於易復發/難治性(R/R)被套細胞淋巴瘤的BCL2抑制劑

businesswire.com
ONC

BeOne Medicinesの「BEQALZI ™」(ソンロトクラックス)、再発・難治性マントル細胞リンパ腫に対する初かつ唯一のBCL2阻害薬として米国FDAが承認

businesswire.com
ONC

DISCOVERY+ NOW AVAILABLE TO SPECTRUM TV CUSTOMERS AT NO EXTRA COST

prnewswire.com
CHTR

BEQALZI ™ (sonrotoclax) de BeOne Medicines, aprobado por la FDA como el primer y único inhibidor de BCL2 para el linfoma de células del manto recidivante/refractario

businesswire.com
ONC
View all news →